Timothy Sangiovanni
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Timothy Sangiovanni
Timothy Sangiovanni is recorded as CFO at Zevra Therapeutics, Inc. (ZVRA). Zevra Therapeutics, Inc. reported in an 8-K filed December 17, 2025 that Timothy Sangiovanni was appointed interim principal financial officer, effective January 1, 2026.
“On December 11, 2025, the board of directors (the "Board") of Zevra Therapeutics, Inc. (the "Company") appointed Timothy Sangiovanni, the Company's current Senior Vice President, Finance and Corporate Controller and principal accounting officer, as interim principal financial officer, effective as of January 1, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Zevra Therapeutics, Inc. (ZVRA)
SEC 8-K
Current2026-01-01–present
-
Current
2026-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Zevra Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Christal M.M. Mickle CEO
- Neil F. McFarlane CEO, Board Member
- Richard W. Pascoe CEO
- Matthew R. Plooster Chairman
- Richard Pascoe Chairman
- Tamara A. Favorito Chairman
- Alicia Secor Board Member
- Alvin Shih, M.D. Board Member
- Christopher A. Posner Board Member
- Corey Watton Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.